18 F-FDG PET/CT Imaging of a Grade 3 Lymphomatoid Granulomatosis in an Immunocompromised Pediatric Patient Primer İmmün Yetmezliği Olan Evre 3 Lenfomatoid Granülomatozis Tanılı Pediatrik Bir Hastanın18F-FDG PET/BT Görüntülemesi

Creative Commons License

KESİM S., Şen F., ÖZGÜVEN S., ÖNEŞ T.

Molecular Imaging and Radionuclide Therapy, cilt.32, sa.1, ss.68-70, 2023 (Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 1
  • Basım Tarihi: 2023
  • Doi Numarası: 10.4274/mirt.galenos.2022.32848
  • Dergi Adı: Molecular Imaging and Radionuclide Therapy
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.68-70
  • Anahtar Kelimeler: 18F-FDG PET/CT, Lymphomatoid granulomatosis, pulmonary involvement
  • Marmara Üniversitesi Adresli: Evet

Özet

Lymphomatoid granulomatosis is a rare extranodal Epstein-Barr virus-driven B-cell lymphoproliferative disease, involving predominantly lung, less often skin, kidney, and central nervous system. Here, we present a pediatric case with primary immunodeficiency, diagnosed with pathologically proven pulmonary grade-III lymphomatoid granulomatosis.18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) imaging demonstrated18F-FDG avid pulmonary masses with central air-bronchograms and cavitations. Although the definitive diagnosis depends on biopsy,18F-FDG PET/CT serves as a complementary imaging tool to evaluate the extent of the disease and response to treatment.